Executive Series 26 Jun 18: Wattle Health Australia (WHA) CEO, Lazarus Karasavvidis, page-104

Mr Market is always overreacting to news either good or bad. Bellamy's share price is a perfect example, $1 to $16, down to $3.7 then ran to $22.

I think the SAMR approval is paramount then organic infant formula will be the key driver of future growth. Australia sourced organic milk is where caused pain to Bellamy's especially SAMR/CFDA requires to provide origin country of milk source.

So far I didn't see any negative signs of being rejected. Mason's large shareholder has strong relationship to Chinese centre government, WHA signed sale/ distribution agreement with a Chinese state owned company. also has Chinese director.

have to weigh pros and cons.